(Australia-NewsWire.Com, September 25, 2017 ) As humans grows and develops, depending on the interactions they made, circumstances they live in some genes become dormant or active to make who they are. Epigenetics is the study of these changes and factors that influence them. These changes decide how a cell should act and it may cause diseases like cancer sometimes. These epigenomes are sometimes inherited by their offspring.
Some of the factors like rising prevalence of cancer, increasing funding in R&D, and increasing frequency of research activities are driving the growth of the Industry. However, lack of trained professionals and high cost of instruments are some of the factors restraining the Industry.
Asia-Pacific Epigenetics Industry is segmented based on Product and Research Area. Based on Product, Industry is segmented into Enzymes, Instruments & Consumables, KITS, and Reagents. Based on Research Area, Industry is segmented into Developmental Biology, Oncology, Drug Delivery. Based on Enzymes, Industry is further segmented into DNA-Modifying Enzymes, Protein-Modifying Enzymes, RNA-Modifying Enzymes. Further based on Instruments & Consumables, Industry is segmented into Mass Spectrometers, Next-Generation Sequencers, QPCR, Sonicators, and others. Based on KITS, Industry is further segmented into Bisulfite Conversion KITS, Chip-Sequence KITS, RNA Sequencing KITS, Whole-Genome Amplification KITS, 5-HMC and 5-MC Analysis KITS, others. Based on Reagents, Industry is further segmented into Antibodies, buffers, Histones, Magnetic Beads, Primers and others. Oncology segment holds the highest share in the Industry but drug discovery segment is expected to grow at highest CAGR during Forecast Period.
Geographically, Industry is further segmented into India, China, Japan, Australia and South Korea. Asia-Pacific Industry is expected to grow at highest CAGR during the forecast period owing to the developing countries like India and China, and increasing R&D spending by companies.
Major players in the Asia-Pacific epigenetics Industry are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation.
Key Points from Table of Contents Overview Executive Summary Key Inferences New Developments Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) Asia-Pacific Epigenetics Industry: Segmentation Product o Enzymes o Instruments & Consumables o KITS o Reagents Research Area o Developmental Biology o Oncology o Drug Delivery Geographical Analysis China India Japan South Korea Australia Strategic Analysis PESTLE analysis Porters Five analysis Industry Leaders' Analysis Competitive Landscape
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.